UNSPSC 51123207: Mexiletine

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C11H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1U511HHV4Z, chemically known as 2-propanamine, 1-(2,6-dimethylphenoxy)- but more generally known as mexiletine, which bears US NIH Compound Identifier 4178. European Medicines Agency schedules Mexiletine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08931MIG.

UNSPSC 51123207 Mexiletine is a Commodity code designating a specific antiarrhythmic medication, but recent state and local procurement activity under this code centers on broader advanced life support medication procurement rather than mexiletine specifically. The City of Tampa's Fire Rescue Department solicited sealed bids in April 2026 (IFB 26P00188) for a bundle of four ALS medications—labetalol, epinephrine, adenosine, and diltiazem—with an estimated contract value of $40,000 and a one-year term plus renewal options. State and local governments use codes at this tier to procure emergency medical supplies, OTC pharmaceuticals, and generic multi-source drugs through both direct municipal purchasing and cooperative vehicles. The issuing bodies span city fire departments, state health agencies, and multistate cooperative purchasing alliances, with Tampa Fire Rescue and the Texas Health and Human Services Commission and Minnesota's Department of Administration representing recent activity across different jurisdictional levels and procurement models.

Geographic activity appears concentrated in the South and Midwest, with recent solicitations from Florida (Tampa), Texas (HHS RFI for direct-to-manufacturer prescriptions), and Minnesota (MMCAP RFP for generic multi-source pharmaceuticals across multiple states including Oregon). The Minnesota Multistate Cooperative Purchasing Alliance RFP issued in January 2026 (due March 26) sought manufacturers of generic pharmaceuticals and OTC products for distribution to state and local facilities across participating jurisdictions, requiring cGMP and DSCSA compliance with pricing through three authorized wholesalers. Tampa's IFB includes a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000. The Texas HHS RFI (posted April 3, 2026) represents exploratory procurement activity aimed at developing direct-to-manufacturer prescription fulfillment models, with no formal award value or timeline specified at the information-gathering stage.